Salivary production rates fall with age in subjects having anti‐centromere, anti‐Ro, and/or anti‐La antibodies

References

• Bell M., Askari A., Bookman A., Frydrych S., Lamont J., McComb J., et al. Sjögren's syndrome: a critical review of clinical management. J Rheumatol 1999; 26: 2051–61
   PubMed Web of Science ®Google Scholar
• Vitali C., Bombardieri S., Jonsson R., Moutsopoulos H. M., Alexander E. L., Carsons S. E., et al. European Study Group on Classification Criteria for Sjögren's Syndrome. Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American–European Consensus Group. Ann Rheum Dis 2002; 61: 554–8
   PubMed Web of Science ®Google Scholar
• Fujibayashi T., Sugai S., Miyasaka N., Hayashi Y., Tsubota K. Revised Japanese criteria for Sjögren's syndrome (1999): availability and validity. Modern Rheumatol 2004; 14: 425–34
   PubMedGoogle Scholar
• McCarty G. A., Rice J. R., Bembe M. L., Barada F. A Jr. Anticentromere antibody. Clinical correlations and association with favorable prognosis in subjects with scleroderma variants. Arthritis Rheum 1983; 26: 1–7
   PubMedGoogle Scholar
• Renier G., Le Normand I., Carrere F., Chevailler A., Hurez D. Anticentromere autoantibodies and Sicca syndrome. Br J Rheumatol 1994; 33: 193
   PubMedGoogle Scholar
• Vlachoyiannopoulos P. G., Drosos A. A., Wiik A., Moutsopoulos H. M. Subjects with anticentromere antibodies, clinical features, diagnoses and evolution. Br J Rheumatol 1993; 32: 297–301
   PubMedGoogle Scholar
• Caramaschi P., Biasi P., Manzo T., Carletto A., Poli F., Bambara L. M. Anticentromere antibody clinical associations. A study of 44 patients. Rheumatol Int 1995; 14: 253–5
   PubMed Web of Science ®Google Scholar
• Katano K., Kawano M., Koni I., Sugai S., Muro Y. Clinical and laboratory features of anticentromere antibody positive primary Sjögren's syndrome. J Rheumatol 2001; 28: 2238–44
   PubMed Web of Science ®Google Scholar
• Izumi M., Eguchi K., Nakamura H., Takagi Y., Kawabe Y., Nakamura T. Corticosteroid irrigation of parotid gland for treatment of xerostomia in subjects with Sjögren's syndrome. Ann Rheum Dis 1998; 57: 464–9
   PubMed Web of Science ®Google Scholar
• Nakamura H., Kawakami A., Tominaga M., Hida A., Yamasaki S., Migita K. Relationship between Sjögren's syndrome and human T‐lymphotropic virus type I infection: follow‐up study of 83 subjects. J Lab Clin Med 2000; 135: 139–44
   PubMed Web of Science ®Google Scholar
• Kohler P. F., Winter M. E. A quantitative test for xerostomia. The Saxon test, an oral equivalent of the Schirmer test. Arthritis Rheum 1985; 28: 1128–32
   PubMed Web of Science ®Google Scholar
• Ship J. A., Baum B. J. Is reduced salivary flow normal in old people?. Lancet 1990; 336: 1507
   PubMedGoogle Scholar
• Ship J. A., Nolan N. E., Puckett S. A. Longitudinal analysis of parotid and submandibular salivary flow rates in healthy, different‐aged adults. J Gerontol A Biol Sci Med Sci 1995; 50: M285–9
   PubMed Web of Science ®Google Scholar
• Ghezzi E. M., Wagner‐Lange L. A., Schork M. A., Metter E. J., Baum B. J., Streckfus C. F., et al. Longitudinal influence of age, menopause, hormone replacement therapy, and other medications, and other medications on parotid flow rates in healthy women. J Gerontol A Biol Sci Med Sci 2000; 55: M34–42
   PubMed Web of Science ®Google Scholar
• Tan E. M., Cohen A. S., Fries J. F., Masi A. T., McShane D. J., Rothfield N. F., et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271–7
   PubMed Web of Science ®Google Scholar
• Arnett F. C., Edworthy S. M., Bloch D. A., McShane D. J., Fries J. F., Cooper N. S., et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315–24
   PubMed Web of Science ®Google Scholar
• LeRoy E. C., Trojanowska M., Smith E. A. The pathogenesis of scleroderma (systemic sclerosis, SSc). Clin Exp Rheumatol 1991; 9: 173–7
   PubMedGoogle Scholar
• Pillimer S. R. Sjögren's syndrome. Primer on the rheumatic diseases, 12th edn, J. H Klippel. The Arthritis Foundation, Atlanta 2001; 377–84
   Google Scholar
• Cavill D., Waterman S. A., Gordon T. P. Antibodies raised against the second extracellular loop of the human muscarinic M3 receptor mimic functional autoantibodies in Sjögren's syndrome. Scand J Immunol 2004; 59: 261–6
   PubMed Web of Science ®Google Scholar
• Reina S., Sterin‐Borda L., Orman B., Borda E. Autoantibodies against cerebral muscarinic cholinoceptors in Sjögren syndrome: functional and pathological implications. J Neuroimmunol 2004; 150: 107–15
   PubMedGoogle Scholar
• McCune A. B., Weston W. L., Lee L. A. Maternal and fetal outcome in neonatal lupus erythematosus. Ann Int Med 1987; 106: 518–23
   PubMed Web of Science ®Google Scholar
• Waltuck J., Buyon J. P. Autoantibody‐associated congenital heart block: outcome in mothers and children. Ann Int Med 1994; 120: 544–51
   PubMed Web of Science ®Google Scholar
• Julkunen H., Eronen M. Long‐term outcome of mothers of children with isolated heart block in Finland. Arthritis Rheum 2001; 44: 647–52
   PubMed Web of Science ®Google Scholar
• Ventura A., Not T., Tommasini A., Marzari R., Sblattero D. Autoantibodies as predictors of disease. Lancet 2004; 364: 1403–4
   PubMedGoogle Scholar
• Arbuckle M. R., McClain M. T., Rubertone M. V., Scofield R. H., Dennis G. J., James J. A., et al. Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med 2003; 349: 1526–33
   PubMed Web of Science ®Google Scholar
• Earnshaw W. C., Sullivan K. F., Machlin P. S., Cooke C. A., Kaiser D. A., Pollard T. D., et al. Molecular cloning of cDNA for CENP‐B, the major human centromere autoantigen. J Cell Biol 1987; 104: 817–29
   PubMed Web of Science ®Google Scholar
• Gonzalez‐Buitrago J. M., Gonzalez C., Hernando M., Carrasco R., Sanchez A., Navajo J. A., et al. Antibodies to centromere antigens measured by an automated enzyme immunoassay. Clin Chim Acta 2003; 328: 135–8
   PubMedGoogle Scholar